This report does not constitute a rating action. CRH posted a strong performance in the first nine months of 2025, with year-over-year revenue up 5.2% to $28.0 billion, supported by positive underlying demand, continued pricing momentum, and contributions from bolt-on and strategic acquisitions. S&P Global Ratings-adjusted EBITDA increased to $5.8 billion, resulting in a slight improvement in the EBITDA margin to 20.7% from 19.9% as of Dec. 31, 2024, reflecting operational efficiencies and acquisition synergies. These strong results prompted CRH to raise its full-year guidance, now anticipating company adjusted EBITDA of $7.6 billion-$7.7 billion, which is in line with our forecast. For 2025-2026, we forecast revenue growth of 5%-7% and S&P Global Ratings-adjusted EBITDA margins of 20%-21%. We anticipate this